INSULET CORPORATION Loss Contingency, Loss in Period
INSULET CORPORATION (PODD) reported Loss Contingency, Loss in Period of $11.70 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-06.
Financial Statements › Notes › Disaggregation of Income Statement Expense, Tabular Integration of Other Disclosure Requirements, Included Entirely in One Caption
us-gaap:LossContingencyLossInPeriod · last filed 2026-05-06
- INSULET CORPORATION loss contingency, loss in period for the quarter ending 2026-03-31 was $11.70M.
| Period end | Loss Contingency, Loss in Period 3 month |
|---|---|
| 2026-03-31 | $11.70M 10-Q · filed 2026-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |